CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 170,000 enrolled
Drug / intervention
No AKI +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03353389
NCT03353389N/ACompleted

Review of Trend in Incidence and Characteristics of Hospital-acquired Acute Kidney Injury in Hospital Selayang

Selayang Hospital·observational·Posted Nov 27, 2017·Updated May 19, 2022

In Brief

An observational study evaluating No AKI, CA-AKI, and 1 other intervention for Acute Kidney Injury and 3 related conditions. Completed, enrolled 170,000 participants across 1 site.

Detailed Summary

This retrospective cohort study aims to investigate the incidence, risk factors and outcomes of Hospital-acquired Acute Kidney Injury in Hospital Selayang, a tertiary hospital at Malaysia, over 15 years.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesMalaysia
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 27, 2017
Enrollment StartNov 1, 2017
Primary CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 8.6 years ago

Interventions

No AKIother

Subjects will be allocated into this group if they did not acquire Acute Kidney Injury during admission.

CA-AKIother

CA-AKI is defined by any patient who developed AKI (as per definition below) within 48 hours of hospital admission. Definition of AKI: i. An increase in serum creatinine of 0.3 mg/dl (26.5 μmol/l) within 48 hours OR ii. An increase in serum creatinine to more or equal to 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days Definition for baseline creatinine: i. The baseline creatinine level is defined as the creatinine level at or within 7 days before the hospital admission, OR ii. at the hospital admission OR iii. the lowest creatinine (excluding the post dialysis creatinine if dialysis is initiated) during the index hospitalisation for those whose baseline creatinine were unknown.

HA-AKIother

HA-AKI is defined by any patient who developed AKI (as per definition below) after 48 hours of hospital admission. Definition of AKI: i. An increase in serum creatinine of 0.3 mg/dl (26.5 μmol/l) within 48 hours OR ii. An increase in serum creatinine to more or equal to 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days Definition for baseline creatinine: i. The baseline creatinine level is defined as the creatinine level at or within 7 days before the hospital admission, OR ii. at the hospital admission OR iii. the lowest creatinine (excluding the post dialysis creatinine if dialysis is initiated) during the index hospitalisation for those whose baseline creatinine were unknown.